Cite
HARVARD Citation
Ding, X. et al. (2018). Have we reached proton beam therapy dosimetric limitations? – A novel robust, delivery-efficient and continuous spot-scanning proton arc (SPArc) therapy is to improve the dosimetric outcome in treating prostate cancer. Acta oncologica. pp. 435-437. [Online].